Cargando…
Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network
The EPIC consortium brings together experts from a wide range of fields that include clinical, molecular and basic microbiology, infectious diseases, computational biology and chemistry, drug discovery and design, bioinformatics, biochemistry, biophysics, pharmacology, toxicology, veterinary science...
Autores principales: | Dahdouh, Elias, Allander, Lisa, Falgenhauer, Linda, Iorga, Bogdan I., Lorenzetti, Stefano, Marcos-Alcalde, Íñigo, Martin, Nathaniel I., Martínez-Martínez, Luis, Mingorance, Jesús, Naas, Thierry, Rubin, Joseph E., Spyrakis, Francesca, Tängdén, Thomas, Gómez-Puertas, Paulino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456441/ https://www.ncbi.nlm.nih.gov/pubmed/36077146 http://dx.doi.org/10.3390/ijms23179746 |
Ejemplares similares
-
Structural and Functional Aspects of Class A Carbapenemases
por: Naas, Thierry, et al.
Publicado: (2016) -
Intestinal loads of extended-spectrum beta-lactamase and Carbapenemase genes in critically ill pediatric patients
por: Dahdouh, Elias, et al.
Publicado: (2023) -
Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae
por: Allander, Lisa, et al.
Publicado: (2022) -
Global Spread of Carbapenemase-producing Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2011) -
To Be or Not to Be an OXA-48 Carbapenemase
por: Dabos, Laura, et al.
Publicado: (2022)